A gradually recovering exit market helped drive shorter-term venture capital performance upward in the first quarter of 2010 while the ten-year horizon continued to decline, according to the Cambridge Associates US Venture Capital Index, the performance benchmark of the National Venture Capital Association. Certain time horizons saw an increase in
The Private Equity Council has presented evidence showing the industry outperformed public markets by an average of seven per cent and 11 per cent over three and five years. The figures contradict claims by the Centre for the Study of Financial Innovation that the industry produced disappointing average returns whilst
Foundation Venture Capital Group, a New Jersey Health Foundation affiliate, has sold its equity interest in Longevica Pharmaceuticals to Rostock International. Longevica, a Princeton, New Jersey-based company, is involved in developing kinase inhibitors that may keep normal cells healthy during chemotherapy or radiation treatments. Rostock International is a subsidiary of
BlueArc, a network storage provider, has closed USD20m of funding led by Investor Growth Capital, the wholly owned venture capital arm of Stockholm-based Investor AB. The round was also supported by 16 existing investors. "After extensive research and diligence with BlueArc, their customers and industry experts, it’s clear that BlueArc
Venture investors put EUR1.1bn into 289 deals for European companies during the second quarter of 2010, a 50 per cent increase in investment from the year-ago period, which saw record-low investment levels. The statistics from industry-tracker Dow Jones VentureSource show that in the second quarter of 2009, 252 deals raised
Private equity firm The Jordan Company has signed a definitive agreement for The Resolute Funds I and II to sell HGI Holdings, a mail order distributor of medical supplies serving chronic disease patients. The company is being acquired by private equity firms Clayton Dubilier & Rice and GS Capital Partners.
Private equity firm Riverside has completed its first deal in Spain with the acquisition of Celvitae, a private cord blood bank. Celvitae has been acquired by Riverside Europe Fund IV as an add-on to Crioestaminal Group. Founded in 2007, Celvitae is licensed by the General Directorate for Regulation and Inspection
Approximately one-third of private equity firm managers believe the credit crisis was resolved in 2009, while an additional ten per cent predict that market weakness will dissipate before the second half of this year. In total, more than 80 per cent of private equity professionals surveyed suggest that the credit
Funds advised by BC Partners and Lion Capital have reached an agreement whereby Lion Capital has been granted a period of exclusivity for the purposes of reaching a definitive agreement for Picard with BC Partners. The communication and consultation process with employee representatives is expected to start before the end
Accel-KKR, a technology-focused private equity investment firm, has reached a definitive agreement to sell iTradeNetwork, a provider of supply chain management software and business intelligence solutions to the food industry, to Roper Industries for USD525m in cash. iTradeNetwork’s solutions allow distributors, manufacturers, operators, retailers, suppliers and wholesalers to reduce cost,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
